Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000409709 | SCV000489280 | likely pathogenic | Familial cancer of breast | 2016-09-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000409709 | SCV004504493 | pathogenic | Familial cancer of breast | 2023-03-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Met304Trpfs*16) in the CHEK2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHEK2 are known to be pathogenic (PMID: 21876083, 24713400). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 371957). This variant has not been reported in the literature in individuals affected with CHEK2-related conditions. This variant is not present in population databases (gnomAD no frequency). |